Michelle Mello

Michelle Mello Stanford

Michelle Mello, JD, PhD

  • Professor, Health Policy
  • Professor, Law
(650) 725-3894 (voice)

Biography

Michelle Mello is Professor of Law at Stanford Law School and Professor of Health Policy in the Department of Health Policy at Stanford University School of Medicine.  She conducts empirical research into issues at the intersection of law, ethics, and health policy.  She is the author of more than 230 articles on medical liability, public health law, the public health response to COVID-19, pharmaceuticals and vaccines, biomedical research ethics and governance, health information privacy, and other topics.
 
The recipient of a number of awards for her research, Dr. Mello was elected to the National Academy of Medicine at the age of 40.  From 2000 to 2014, she was a professor at the Harvard School of Public Health, where she directed the School’s Program in Law and Public Health.
 
Dr. Mello teaches courses in torts, public health law, and health policy.  She holds a J.D. from the Yale Law School, a Ph.D. in Health Policy and Administration from the University of North Carolina at Chapel Hill, an M.Phil. from Oxford University, where she was a Marshall Scholar, and a B.A. from Stanford University. 

In The News

Scientific American Podcast Illustration
News

Podcast Looks at Public Health System on 5th Anniversary of Pandemic

This week marks the fifth anniversary of COVID being declared a global pandemic. SHP's Michelle Mello joins the Science Quickly podcast for Scientific American.
Podcast Looks at Public Health System on 5th Anniversary of Pandemic
A sign for a County Health Department
Commentary

The Hard Road Ahead for Public Health Departments

Public health officials—already on the defensive due to the backlash against COVID-19 pandemic orders—are now facing a lack of support from the federal government, leaving them alone on the front lines to promote health while battling disease.
The Hard Road Ahead for Public Health Departments
Illustration of a piggy bank and prescription drug
News

Extending Prescription Drug Inflationary Rebates to Commercial Health Plans

A new study by SHP's Marissa Reitsma and Michelle Mello finds that extending prescription drug rebates to commercial health plans could lead to big savings.
Extending Prescription Drug Inflationary Rebates to Commercial Health Plans